Literature DB >> 17323047

Does invasive diagnosis of nosocomial pneumonia during off-hours delay treatment?

Charles-Edouard Luyt1, Alain Combes, Ania Nieszkowska, Catherine Reynaud, Marc Tonnellier, Jean-Louis Trouillet, Jean Chastre.   

Abstract

OBJECTIVE: We examined whether invasive lung-specimen collection-to-treatment times for intensive care unit patients with suspected ventilator-associated pneumonia (VAP) differ with to the work shift during which specimens were collected. We compared weekday day shifts and off-hours (from 6:30 p.m. to 8:29 a.m. the next day for night shifts, from Saturday 1:00 p.m. to Monday 8:29 a.m. for weekends, and from 8:30 a.m. to 8:29 a.m. the following morning for public holidays). DESIGN AND
SETTING: Single-center, observational study in the intensive care unit in an academic teaching hospital. PATIENTS AND PARTICIPANTS: 101 patients who developed 152 episodes of bacteriologically confirmed VAP. MEASUREMENTS AND
RESULTS: Of the 152 VAP episodes 66 were diagnosed during off-hours. Neither more bronchoscopy complications nor more inappropriate initial antimicrobial treatments for patients were observed between day and off-hour shifts. Indeed, the overall time from brochoalveolar lavage to antibiotic administration was shorter for off-hours than day-shifts due to shorter specimen collection-to-antibiotic prescription times, but antibiotic prescription-to-administration times were the same.
CONCLUSIONS: An invasive strategy based on bronchoscopy to diagnose VAP was not associated with a longer time to first appropriate antibiotic administration when clinical suspicion of VAP occurs during off-hours.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17323047     DOI: 10.1007/s00134-007-0562-x

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  15 in total

Review 1.  Use of quantitative cultures and reduced duration of antibiotic regimens for patients with ventilator-associated pneumonia to decrease resistance in the intensive care unit.

Authors:  Jean Chastre; Charles-Edouard Luyt; Alain Combes; Jean-Louis Trouillet
Journal:  Clin Infect Dis       Date:  2006-09-01       Impact factor: 9.079

2.  Pseudomonas aeruginosa ventilator-associated pneumonia: comparison of episodes due to piperacillin-resistant versus piperacillin-susceptible organisms.

Authors:  J L Trouillet; A Vuagnat; A Combes; N Kassis; J Chastre; C Gibert
Journal:  Clin Infect Dis       Date:  2002-03-15       Impact factor: 9.079

3.  Hospital mortality rate and length of stay in patients admitted at night to the intensive care unit.

Authors:  Ian J Morales; Steve G Peters; Bekele Afessa
Journal:  Crit Care Med       Date:  2003-03       Impact factor: 7.598

4.  Conference summary: ventilator-associated pneumonia.

Authors:  Jean Chastre
Journal:  Respir Care       Date:  2005-07       Impact factor: 2.258

5.  Role of serial routine microbiologic culture results in the initial management of ventilator-associated pneumonia.

Authors:  Jan Hayon; Corinne Figliolini; Alain Combes; Jean-Louis Trouillet; Najibi Kassis; Marie Christine Dombret; Claude Gibert; Jean Chastre
Journal:  Am J Respir Crit Care Med       Date:  2002-01-01       Impact factor: 21.405

Review 6.  Ventilator-associated pneumonia.

Authors:  Jean Chastre; Jean-Yves Fagon
Journal:  Am J Respir Crit Care Med       Date:  2002-04-01       Impact factor: 21.405

7.  Mortality among patients admitted to intensive care units during weekday day shifts compared with "off" hours.

Authors:  Charles-Edouard Luyt; Alain Combes; Philippe Aegerter; Bertrand Guidet; Jean-Louis Trouillet; Claude Gibert; Jean Chastre
Journal:  Crit Care Med       Date:  2007-01       Impact factor: 7.598

8.  Hospital mortality associated with day and time of admission to intensive care units.

Authors:  Hannah Wunsch; James Mapstone; Tony Brady; Rosa Hanks; Kathryn Rowan
Journal:  Intensive Care Med       Date:  2004-03-09       Impact factor: 17.440

9.  Impact of adequacy of initial antimicrobial therapy on the prognosis of patients with ventilator-associated pneumonia.

Authors:  Olivier Leroy; Agnès Meybeck; Thibaud d'Escrivan; Patrick Devos; Eric Kipnis; Hugues Georges
Journal:  Intensive Care Med       Date:  2003-09-12       Impact factor: 17.440

10.  Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia.

Authors:  Manuel Iregui; Suzanne Ward; Glenda Sherman; Victoria J Fraser; Marin H Kollef
Journal:  Chest       Date:  2002-07       Impact factor: 9.410

View more
  4 in total

Review 1.  Year in review in Intensive Care Medicine, 2007. II. Haemodynamics, pneumonia, infections and sepsis, invasive and non-invasive mechanical ventilation, acute respiratory distress syndrome.

Authors:  Massimo Antonelli; Elie Azoulay; Marc Bonten; Jean Chastre; Giuseppe Citerio; Giorgio Conti; Daniel De Backer; François Lemaire; Herwig Gerlach; Johan Groeneveld; Goran Hedenstierna; Duncan Macrae; Jordi Mancebo; Salvatore M Maggiore; Alexandre Mebazaa; Philipp Metnitz; Jerme Pugin; Jan Wernerman; Haibo Zhang
Journal:  Intensive Care Med       Date:  2008-01-31       Impact factor: 17.440

2.  Microbiogical data, but not procalcitonin improve the accuracy of the clinical pulmonary infection score.

Authors:  Boris Jung; Nathalie Embriaco; François Roux; Jean-Marie Forel; Didier Demory; Jérôme Allardet-Servent; Samir Jaber; Bernard La Scola; Laurent Papazian
Journal:  Intensive Care Med       Date:  2010-03-09       Impact factor: 17.440

3.  Usefulness of procalcitonin for the diagnosis of ventilator-associated pneumonia.

Authors:  Charles-Edouard Luyt; Alain Combes; Catherine Reynaud; Guillaume Hekimian; Ania Nieszkowska; Marc Tonnellier; Alexandra Aubry; Jean-Louis Trouillet; Maguy Bernard; Jean Chastre
Journal:  Intensive Care Med       Date:  2008-04-18       Impact factor: 17.440

4.  Pharmacokinetics and lung delivery of PDDS-aerosolized amikacin (NKTR-061) in intubated and mechanically ventilated patients with nosocomial pneumonia.

Authors:  Charles-Edouard Luyt; Marc Clavel; Kalpalatha Guntupalli; Jay Johannigman; John I Kennedy; Christopher Wood; Kevin Corkery; Dennis Gribben; Jean Chastre
Journal:  Crit Care       Date:  2009-12-10       Impact factor: 9.097

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.